Westover Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.88M Buy
7,920
+719
+10% +$149K 0.31% 67
2026
Q1
$1.52M Buy
7,201
+1,735
+32% +$374K 0.28% 73
2025
Q4
$1.12M Buy
5,466
+723
+15% +$136K 0.2% 92
2025
Q3
$744K Buy
4,743
+481
+11% +$74.3K 0.14% 116
2025
Q2
$716K Buy
4,262
+1,837
+76% +$273K 0.14% 120
2025
Q1
$334K Buy
2,425
+665
+38% +$84.8K 0.07% 181
2024
Q4
$208K Buy
+1,760
New +$205K 0.05% 230

Other funds holding CAH

Westover Capital Advisors's CAH Position: Q2 2026 in Review

Westover Capital Advisors increased its Cardinal Health (CAH) stake by 10% in Q2 2026, buying an estimated $149K and bringing the position to 7,920 shares worth $1.88M. The position accounts for 0.31% of the portfolio, ranked #67.

Westover Capital Advisors first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Westover Capital Advisors held 7,920 shares of Cardinal Health worth $1.88M as of Q2 2026.
  • Westover Capital Advisors bought 719 Cardinal Health shares in Q2 2026, an estimated $149K.
  • Cardinal Health made up 0.31% of Westover Capital Advisors's portfolio in Q2 2026, its #67 holding.
  • Westover Capital Advisors first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.